Literature DB >> 22160649

Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Shinichi Nakamura1, Kazuo Awai, Daisuke Utsunomiya, Tomohiro Namimoto, Takeshi Nakaura, Kosuke Morita, Yasuyuki Yamashita.   

Abstract

PURPOSE: To investigate the chronological relationship between scan delay and liver enhancement for the hepatobiliary phase on Gd-EOB-DTPA-enhanced MRI and evaluate the effects of liver function on liver enhancement.
MATERIALS AND METHODS: Hepatobiliary-phase images were retrospectively evaluated in 125 patients with chronic liver disease. Hepatobiliary phase images were obtained at 5, 10, 15, and 20 min after injection. We calculated relative liver enhancement (RLE) at t min after injection by dividing the signal intensity (SI) of the liver at t min by precontrast SI. We compared RLE values at 5, 10, 15, and 20 min and evaluated the detectability of focal hepatic lesions. We analyzed the effect of liver function on RLE with the generalized linear model.
RESULTS: There was not significant difference in RLE and lesion detectability at 15 and 20 min. RLE in the Child-Pugh C group was significantly lower than in the Child-Pugh A and B groups. The serum albumin level and prothrombin time were significantly correlated with the liver enhancement.
CONCLUSION: A delay time of 15 min for the hepatobiliary phase was thought to be adequate in patients with mild liver dysfunction. The serum albumin level and prothrombin time would be predictive of liver enhancement in the hepatobiliary phase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160649     DOI: 10.1007/s11604-011-0003-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  31 in total

1.  Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA.

Authors:  T Kim; T Murakami; Y Hasuike; M Gotoh; N Kato; M Takahashi; T Miyazawa; Y Narumi; M Monden; H Nakamura
Journal:  J Magn Reson Imaging       Date:  1997 Jul-Aug       Impact factor: 4.813

2.  Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Authors:  Kazuhiro Saito; Fumio Kotake; Naoki Ito; Taizo Ozuki; Ryuji Mikami; Kimihiko Abe; Yoko Shimazaki
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

3.  Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation.

Authors:  M Bollow; M Taupitz; B Hamm; T Staks; K J Wolf; H J Weinmann
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

4.  [Examination of the means of measuring liver function in the hepatobiliary phase].

Authors:  Hiroshige Mori; Ken Furuya; Satoru Akimoto; Risa Ajioka; Takashi Emoto
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2009-11-20

5.  Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

Authors:  Hun-Kyu Ryeom; Seong-Hun Kim; Jong-Yeol Kim; Hye-Jeong Kim; Jong-Min Lee; Yong-Min Chang; Yong-Sun Kim; Duk-Sik Kang
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

6.  Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.

Authors:  L Pascolo; F Cupelli; P L Anelli; V Lorusso; M Visigalli; F Uggeri; C Tiribelli
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

Review 7.  Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.

Authors:  Robert F Hanna; Diego A Aguirre; Norbert Kased; Shawn C Emery; Michael R Peterson; Claude B Sirlin
Journal:  Radiographics       Date:  2008 May-Jun       Impact factor: 5.333

8.  Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Licht Tominaga; Hironobu Sou; Katsuhiro Sano; Shintaro Ichikawa; Tsutomu Araki
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

Review 9.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

10.  Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.

Authors:  Alexander Huppertz; Thomas Balzer; Anthony Blakeborough; Josy Breuer; Andrea Giovagnoni; Gertraud Heinz-Peer; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Mueller; Peter Reimer; Philip J Robinson; Michael Strotzer; Matthias Taupitz; Thomas J Vogl
Journal:  Radiology       Date:  2004-01       Impact factor: 11.105

View more
  5 in total

1.  Abdominal DCE-MRI reconstruction with deformable motion correction for liver perfusion quantification.

Authors:  Adam Johansson; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2018-08-31       Impact factor: 4.071

2.  Radiomics Analysis of MR Imaging with Gd-EOB-DTPA for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Investigation and Comparison of Different Hepatobiliary Phase Delay Times.

Authors:  Shuai Zhang; Guizhi Xu; Chongfeng Duan; Xiaoming Zhou; Xin Wang; Haiyang Yu; Lan Yu; Zhiming Li; Yuanxiang Gao; Ruirui Zhao; Linlin Jiao; Gang Wang
Journal:  Biomed Res Int       Date:  2021-01-07       Impact factor: 3.411

3.  Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.

Authors:  Xijiao Liu; Li Zou; Fei Liu; Yin Zhou; Bin Song
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

Review 4.  Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.

Authors:  Cher Heng Tan; Sudhakar Kundapur Venkatesh
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

5.  Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.

Authors:  Jian-Wei Wu; Yue-Cheng Yu; Xian-Li Qu; Yan Zhang; Hong Gao
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.